Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,002 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis.
Salhotra VS, Sachdeva KS, Kshirsagar N, Parmar M, Ramachandran R, Padmapriyadarsini C, Patel Y, Mehandru L, Jaju J, Ponnuraja C, Gupta M, Kalaiselvan V, Shamim A, Khaparde S, Swaminathan S; Bedaquiline CAP Site Teams. Salhotra VS, et al. Among authors: patel y. Indian J Tuberc. 2020 Jan;67(1):29-37. doi: 10.1016/j.ijtb.2019.10.002. Epub 2019 Oct 16. Indian J Tuberc. 2020. PMID: 32192613
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens.
Sachdeva KS, Arora N, Solanki R, Singla R, Sarin R, Bhatnagar A, Khanna A, Atahavale A, Shridhar R, Barua SR, Parmar M, Farooq SI, Ramachandran R, Alavadi U, Swamickan R, Tonsing J, Patel Y, Singla N. Sachdeva KS, et al. Among authors: patel y. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1067-1072. doi: 10.5588/ijtld.20.0136. Int J Tuberc Lung Dis. 2020. PMID: 33126941
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020).
Sachdeva KS, Parmar M, Patel Y, Gupta R, Rathod S, Chauhan S, Anand S, Ramachandran R. Sachdeva KS, et al. Among authors: patel y. Expert Rev Respir Med. 2021 Jul;15(7):885-898. doi: 10.1080/17476348.2021.1850277. Epub 2021 Jan 21. Expert Rev Respir Med. 2021. PMID: 33307889 Review.
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.
Jeyashree K, Thangaraj J, Rade K, Modi B, Selvaraju S, Velusamy S, Akhil S, Vijayageetha M, Sudha Rani D, Sabarinathan R, Manikandanesan S, Elumalai R, Natarajan M, Joseph B, Mahapatra A, Shamim A, Shah A, Bhardwaj A, Purty A, Vadera B, Sridhar A, Chowdhury A, Shafie A, Choudhury A, Dhrubjyoti D, Solanki H, Sirmanwar K, Khaparde K, Parmar M, Dahiya N, Debdutta P, Ahmed Q, Ramachandran R, Prasad R, Shinde R, Baruah R, Chauhan S, Bharaswadkar S, Achanta S, Sharath BN, Balakrishnan S, Chandra S, Khumukcham S, Mandal S, Chalil S, Shah V, Roddawar V, Rao R, Sachdeva K, Murhekar M; Subnational TB claims verification group. Jeyashree K, et al. BMJ Open. 2022 Jul 28;12(7):e060197. doi: 10.1136/bmjopen-2021-060197. BMJ Open. 2022. PMID: 35902192 Free PMC article.
Capacity Building, Knowledge Enhancement, and Consultative Processes for Development of a Digital Tool (Ni-kshay SETU) to Support the Management of Patients with Tuberculosis: Exploratory Qualitative Study.
Shah H, Patel J, Yasobant S, Saxena D, Saha S, Sinha A, Bhavsar P, Patel Y, Modi B, Nimavat P, Kapadiya D, Fancy M. Shah H, et al. Among authors: patel y, patel j. J Med Internet Res. 2023 Jun 19;25:e45400. doi: 10.2196/45400. J Med Internet Res. 2023. PMID: 37335610 Free PMC article.
1,002 results